Rhino Health has partnered with over 20 global institutions to advance an innovative solution aimed at reducing the environmental impact of computerized tomography (CT) imaging. The company will be part of the NetZeroAICT consortium, which includes the University of Oxford and is co-funded by Horizon Europe and UK Research Innovation.
The project aims to develop AI-powered CT digital contrast technology, which will minimize the environmental footprint of CT imaging by reducing contrast media and single-use consumables. This initiative has the potential to revolutionize the radiology service pathway and reduce the carbon footprint of CT scans globally.
With over 300 million CT scans performed each year worldwide, the average carbon footprint of each scan is 9kg, largely due to single-use consumables and increased energy consumption. Additionally, around 60% of CT scans require the use of iodinated RCM, resulting in significant pharmaceutical waste that affects environmental biodiversity.
The NetZeroAICT consortium seeks to develop a comprehensive CT image repository, leveraging AI models and federated computing platforms to reduce the environmental impact of medical imaging. Rhino Health’s federated computing platform will play a key role in training the AI model and orchestrating workflows to minimize the carbon footprint of the entire project.
Ittai Dayan, MD, co-founder and CEO of Rhino Health, highlighted the company’s commitment to reducing the environmental impact of medical imaging while also powering innovation. The project, coordinated by Collective Minds Radiology and scientifically led by the University of Oxford, aims to align healthcare systems with the European Green Deal and improve planetary health for future generations. This collaboration underscores a new era of translational research that focuses on both patient and planetary health.
